Clinical data from a sub-analysis of patients with M2 occlusions enrolled in the Imperative Trial (n=65) were presented by Justin Mascitelli, M.D., UT Health San Antonio.

ChAS users will be able to access Genoox’s cloud-based AI platform, Franklin, with the launch of CytoScan Automated Interpretation and Reporting (AIR) solution, making cytogenetic research data ...